Stocks
ABIOMED (ABMD) EBITDA US GAAP (year values) |
|||||||||
| FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 164.5 | 230.8 | 257.5 | 246.9 | 500.5 | 469.8 | ||
| Changes by years, y/y, % | +74% | +40% | +12% | -4% | +103% | +39.5% | |||
ABIOMED. EBITDA US GAAP, bln rub
ABIOMED. EBITDA US GAAP, changes, %
ABIOMED. EBITDA US GAAP, sum by quarters, bln rub
ABIOMED (ABMD) EBITDA US GAAP (quarter values) |
||||||||
| FY2022Q2 | FY2022Q3 | FY2022Q4 | FY2023Q1 | FY2023Q2 | LTM ? | |||
| EBITDA, bln rub | ? | 66.4 | 71.6 | 91.8 | 80.2 | 226.1 | 469.8 | |
| Changes by years, y/y, % | +2% | -6% | +34% | -57% | +240% | |||
| Changes by quarters, q/q, % | -65% | +8% | +28% | -13% | +182% | |||
